Search
for
Sort by
Research 571–600 of 1000+
- A rare case of ophiasis pattern of alopecia areata in a child: a case report with Unani insights
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- TREATMENT OF ALOPECIA AREATA WITH ORAL METHYLPREDNISOLONE COMBINED WITH FRACTIONAL MICRONEEDLE RADIOFREQUENCY
- Discriminative models of the possibility of occurrence and features of the course of alopecia areata in Ukrainian men depending on the features of body structure and size indicators
- Combined Alopecia Areata and Acquired Hypertrichosis Lanuginosa in Celiac Disease- A Rarest Phenomenon
- Mechanistic study of Erianin in alopecia areata
- Validation of Siddha Medicine in the Treatment of Alopecia areata in Paediatric Patient: A Case Report
- Comparative investigation of immune-related biomarkers related to alopecia areata subtypes
- Experience in the Treatment of Non-Scarring Alopecia Areata Using a Biomedical Cell Product Based on Autologous Follicular Stem Cells
- Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis
- A case of alopecia areata after rabies vaccination: unreported adverse effect?
- Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Resistance of Transplanted Hair Follicles to the Onslaught of Diffuse Alopecia Areata
- Extensive alopecia areata: A multicenter review of 132 patients
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Alopecia areata update
- Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
- Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I
- The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Quantitative analysis and development of alopecia areata classification frameworks
- Diagnostic challenges in determining alopecia areata
- Understanding the Experience of Healthcare Access and Health-Related Impacts among Individuals with Alopecia Areata
- Alopecia areata in the United States: Outpatient utilization and common prescribing patterns
- ‘The psychosocial burden of alopecia areata and androgenetica’: a cross‐sectional multicentre study among dermatological out‐patients in 13 European countries
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Therapeutic synergy between contact dermatitis from a wig‐fixing device and tofacitinib on alopecia areata